Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: A proof of concept study

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Roy, Hemant K ^a   Brendler, Charles B ^b   Subramanian, Hariharan ^c   Zhang, Di ^c   Maneval, Charles ^c   Chandler, John ^c   Bowen, Leah ^c   Kaul, Karen L ^b   Helfand, Brian T ^b   Wang, Chi Hsiung ^b   Quinn, Margo ^b   Petkewicz, Jacqueline ^b   Paterakos, Michael ^b   Backman, Vadim ^c  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER OVERDIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CASE CONTROL STUDY; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOLOGY; DEMOGRAPHY; EPITHELIUM CELL; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; MICROSCOPY; MUCOSA; NANOCYTOLOGY; NANOTECHNOLOGY; NEEDLE BIOPSY; OBESITY; PARTIAL WAVE SPECTROSCOPIC MICROSCOPY; PREDICTION; PROSTATE CANCER; RACE; SENSITIVITY AND SPECIFICITY; SMOKING; CANCER GRADING; EARLY DIAGNOSIS; HEALTH SERVICE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS;

AGED; CARCINOGENESIS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; HUMANS; MALE; MEDICAL OVERUSE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84923668545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115999     Document Type: Article

References (41)

1. Esserman LJ, Thompson IM Jr., Reid B (2013) Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 310: 797-798. PMID: 23896967
2. Walsh PC, DeWeese TL, Eisenberger MA (2007) Clinical practice. Localized prostate cancer. N Engl J Med 357: 2696-2705. PMID: 18160689
3. Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, et al. (2013) Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J Natl Cancer Inst 105: 1050-1058. doi: 10.1093/jnci/djt151 PMID: 23847245
4. Carter HB (2013) American Urological Association (AUA) guideline on prostate cancer detection: process and rationale. BJU Int 112: 543-547. doi: 10.1111/bju.12318 PMID: 23924423
5. Ganz PA, Barry JM, Burke W, Col NF, Corso PS, et al. (2012) National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med 156: 591-595. doi: 10.7326/0003-4819-156-8-201204170-00401 PMID: 22351514
6. Latini DM, Hart SL, Knight SJ, Cowan JE, Ross PL, et al. (2007) The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol 178: 826-831; discussion 831-822. PMID: 17632144
7. Backman V, Roy HK (2011) Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening. Gastroenterology 140: 35-41. doi: 10.1053/j.gastro.2010.11.023 PMID: 21078318
8. Steiling K RJ, Broady JS, Spira A (2008) the field of tissue injury in the lung and airway. Cancer Prev Res 1: 396-403. doi: 10.1158/1940-6207.CAPR-08-0174 PMID: 19138985
9. Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, et al. (2014) Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol.
10. Dotto GP (2014) Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J Clin Invest 124: 1446-1453. doi: 10.1172/JCI72589 PMID: 24691479
11. Kosari F, Cheville JC, Ida CM, Karnes RJ, Leontovich AA, et al. (2012) Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer. Am J Pathol 181: 34-42. doi: 10.1016/j.ajpath.2012.03.043 PMID: 22640805
12. Luo JH, Ding Y, Chen R, Michalopoulos G, Nelson J, et al. (2013) Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. Am J Pathol 182: 2028-2036. doi: 10.1016/j.ajpath.2013.02.040 PMID: 23583283
13. Nonn L, Ananthanarayanan V, Gann PH (2009) Evidence for field cancerization of the prostate. Prostate 69: 1470-1479. doi: 10.1002/pros.20983 PMID: 19462462
14. Parr RL, Mills J, Harbottle A, Creed JM, Crewdson G, et al. (2013) Mitochondria, prostate cancer, and biopsy sampling error. Discov Med 15: 213-220. PMID: 23636138
15. Zhang Y, Perez T, Blondin B, Du J, Liu P, et al. (2014) Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment. BMC Cancer 14: 129. doi: 10.1186/1471-2407-14-129 PMID: 24568597
16. Subramanian H, Pradhan P, Liu Y, Capoglu IR, Li X, et al. (2008) Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells. Proc Natl Acad Sci U S A 105: 20118-20123. doi: 10.1073/pnas.0804723105 PMID: 19073935
17. Damania D, Roy HK, Subramanian H, Weinberg DS, Rex DK, et al. (2012) Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. Cancer Res 72: 2720-2727. doi: 10.1158/0008-5472.CAN-11-3807 PMID: 22491589
18. Roy HK, Subramanian H, Damania D, Hensing TA, Rom WN, et al. (2010) Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. Cancer Res 70: 7748-7754. doi: 10.1158/0008-5472.CAN-10-1686 PMID: 20924114
19. Konda VJ, Cherkezyan L, Subramanian H, Wroblewski K, Damania D, et al. (2013) Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening. Endoscopy 45: 983-988. doi: 10.1055/s-0033-1344617 PMID: 24019132
20. Subramanian H, Roy HK, Pradhan P, Goldberg MJ, Muldoon J, et al. (2009) Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res 69: 5357-5363. doi: 10.1158/0008-5472.CAN-08-3895 PMID: 19549915
21. Damania D, Roy HK, Kunte D, Hurteau JA, Subramanian H, et al. (2013) Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells. Int J Cancer 133: 1143-1152. doi: 10.1002/ijc.28122 PMID: 23436651
22. Backman V, Roy HK (2013) Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification. J Cancer 4: 251-261. doi: 10.7150/jca.5838 PMID: 23459690
23. Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR (2014) Racial Variation in Prostate Cancer Upgrading and Upstaging Among Men with Low-risk Clinical Characteristics. Eur Urol.
24. Sundi D, Kryvenko ON, Carter HB, Ross AE, Epstein JI, et al. (2014) Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J Urol 191: 60-67. doi: 10.1016/j.juro.2013.06.021 PMID: 23770146
25. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR (2007) Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 109: 1192-1202. PMID: 17311344
26. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E Smoking and prostate cancer survival and recurrence. Jama 305: 2548-2555. doi: 10.1001/jama.2011.879 PMID: 21693743
27. Vickers AJ, Thompson IM, Klein E, Carroll PR, Scardino PT (2014) A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology 83: 592-596. doi: 10.1016/j.urology.2013.09.075 PMID: 24581521
28. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64: 9-29. doi: 10.3322/caac.21208 PMID: 24399786
29. Moyer VA, Force USPST (2012) Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157: 120-134. doi: 10.7326/0003-4819-157-2-201207170-00459 PMID: 22801674
30. Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, et al. (2013) Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369: 920-931. doi: 10.1056/NEJMoa1208962 PMID: 24004119
31. Roy HK, Hensing T, Backman V (2011) Nanocytology for field carcinogenesis detection: novel paradigm for lung cancer risk stratification. Future Oncol 7: 1-3. doi: 10.2217/fon.10.176 PMID: 21174531
32. Irshad S, Bansal M, Castillo-Martin M, Zheng T, Aytes A, et al. (2013) A molecular signature predictive of indolent prostate cancer. Sci Transl Med 5: 202ra122. doi: 10.1126/scitranslmed.3006408 PMID: 24027026
33. Sartori DA, Chan DW (2014) Biomarkers in prostate cancer: what's new? Curr Opin Oncol 26: 259-264. doi: 10.1097/CCO.0000000000000065 PMID: 24626128
34. Trujillo KA, Jones AC, Griffith JK, Bisoffi M (2012) Markers of field cancerization: proposed clinical applications in prostate biopsies. Prostate Cancer 2012: 302894. doi: 10.1155/2012/302894 PMID: 22666601
35. Montironi R, Filho AL, Santinelli A, Mazzucchelli R, Pomante R, et al. (2000) Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. Virchows Arch 437: 625-634. PMID: 11193474
36. Campos-Fernandes JL, Bastien L, Nicolaiew N, Robert G, Terry S, et al. (2009) Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 55: 600-606. doi: 10.1016/j.eururo.2008.06.043 PMID: 18597923
37. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359: 1995-2004. doi: 10.1056/NEJMoa0804525 PMID: 18923165
38. Tiwari AK (2013) Partial Wave Spectroscopic Microscopy: A Novel Tool to Assess Perturbation in teh Cellular Transcriptional Activity During Colon Carcinogenesis. Gastroenterology 144: 1.
39. Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, et al. (2004) Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res 64: 3694-3700. PMID: 15150130
40. Damania D, Subramanian H, Tiwari AK, Stypula Y, Kunte D, et al. (2010) Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. Biophys J 99: 989-996. doi: 10.1016/j.bpj.2010.05.023 PMID: 20682278
41. Fillmore RA, Kojima C, Johnson C, Kolcun G, Dangott LJ, et al. (2014) New concepts concerning prostate cancer screening. Exp Biol Med (Maywood) 239: 793-804. PMID: 24928864